Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%
Clinical trial NCT04435626 · COMPLETED
Trial details
- NCT number
- NCT04435626
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-14
- Primary completion
- 2024-05-15
- Enrollment
- 6016
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.